BCRB 2018

Reduction of radiosensitivity differences : Potential therapeutic advantage when the tumor is radioresistant in comparison with healthy tissues

Tumor

Tumor

Healthy tissues

HT

Dose ( high LET) Surviving Fractions (%)

Dose (low LET) Surviving Fractions (%)

Potential therapeutic benefit due to the reduction of an unfavourable differential effect

ESTRO 2018